vs
Side-by-side financial comparison of CALERES INC (CAL) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $790.1M, roughly 1.9× CALERES INC). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs 0.3%, a 4.1% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 6.6%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $-12.4M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 6.5%).
Caleres Inc. is an American footwear company that owns and operates a variety of footwear brands. Its headquarters is located in Clayton, Missouri, a suburb of St. Louis. The company was founded in 1878 as Bryan, Brown & Company in St. Louis, though it underwent several name changes. The Hamilton-Brown Shoe Company was the largest manufacturer of shoes in America in the early 20th century, but it went bankrupt in June 1939.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
CAL vs ONC — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $790.1M | $1.5B |
| Net Profit | $2.4M | $66.5M |
| Gross Margin | 41.8% | 90.5% |
| Operating Margin | 1.5% | 12.4% |
| Net Margin | 0.3% | 4.4% |
| Revenue YoY | 6.6% | 32.8% |
| Net Profit YoY | -94.2% | 143.8% |
| EPS (diluted) | $0.07 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $790.1M | $1.5B | ||
| Q3 25 | $658.5M | $1.4B | ||
| Q2 25 | $614.2M | $1.3B | ||
| Q1 25 | $639.2M | $1.1B | ||
| Q4 24 | $740.9M | $1.1B | ||
| Q3 24 | $683.3M | $1.0B | ||
| Q2 24 | $659.2M | $929.2M | ||
| Q1 24 | $697.1M | $751.7M |
| Q4 25 | $2.4M | $66.5M | ||
| Q3 25 | $6.7M | $124.8M | ||
| Q2 25 | $6.9M | $94.3M | ||
| Q1 25 | $4.9M | $1.3M | ||
| Q4 24 | $41.4M | $-151.9M | ||
| Q3 24 | $30.0M | $-121.3M | ||
| Q2 24 | $30.9M | $-120.4M | ||
| Q1 24 | $55.7M | $-251.2M |
| Q4 25 | 41.8% | 90.5% | ||
| Q3 25 | 43.4% | 86.1% | ||
| Q2 25 | 45.4% | 87.5% | ||
| Q1 25 | 43.0% | 85.2% | ||
| Q4 24 | 44.1% | 85.8% | ||
| Q3 24 | 45.5% | 83.0% | ||
| Q2 24 | 46.9% | 85.1% | ||
| Q1 24 | 43.9% | 83.4% |
| Q4 25 | 1.5% | 12.4% | ||
| Q3 25 | 1.4% | 11.5% | ||
| Q2 25 | 1.9% | 6.7% | ||
| Q1 25 | 1.2% | 1.0% | ||
| Q4 24 | 7.7% | -7.0% | ||
| Q3 24 | 6.2% | -12.0% | ||
| Q2 24 | 6.5% | -11.5% | ||
| Q1 24 | 4.4% | -34.8% |
| Q4 25 | 0.3% | 4.4% | ||
| Q3 25 | 1.0% | 8.8% | ||
| Q2 25 | 1.1% | 7.2% | ||
| Q1 25 | 0.8% | 0.1% | ||
| Q4 24 | 5.6% | -13.5% | ||
| Q3 24 | 4.4% | -12.1% | ||
| Q2 24 | 4.7% | -13.0% | ||
| Q1 24 | 8.0% | -33.4% |
| Q4 25 | $0.07 | $0.05 | ||
| Q3 25 | $0.20 | $0.08 | ||
| Q2 25 | $0.21 | $0.06 | ||
| Q1 25 | $0.17 | $0.00 | ||
| Q4 24 | $1.19 | $-0.10 | ||
| Q3 24 | $0.85 | $-0.09 | ||
| Q2 24 | $0.88 | $-0.09 | ||
| Q1 24 | $1.56 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.0M | $4.5B |
| Total DebtLower is stronger | — | $836.4M |
| Stockholders' EquityBook value | $616.8M | $4.4B |
| Total Assets | $2.1B | $8.2B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.0M | $4.5B | ||
| Q3 25 | $191.5M | $4.0B | ||
| Q2 25 | $33.1M | $2.8B | ||
| Q1 25 | $29.6M | $2.5B | ||
| Q4 24 | $33.7M | $2.6B | ||
| Q3 24 | $51.8M | $2.7B | ||
| Q2 24 | $30.7M | $2.6B | ||
| Q1 24 | $21.4M | $2.8B |
| Q4 25 | — | $836.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $616.8M | $4.4B | ||
| Q3 25 | $613.3M | $4.1B | ||
| Q2 25 | $605.2M | $3.8B | ||
| Q1 25 | $599.0M | $3.5B | ||
| Q4 24 | $598.3M | $3.3B | ||
| Q3 24 | $606.1M | $3.4B | ||
| Q2 24 | $570.3M | $3.4B | ||
| Q1 24 | $560.6M | $3.4B |
| Q4 25 | $2.1B | $8.2B | ||
| Q3 25 | $2.2B | $7.6B | ||
| Q2 25 | $1.9B | $6.3B | ||
| Q1 25 | $1.9B | $5.8B | ||
| Q4 24 | $2.0B | $5.9B | ||
| Q3 24 | $2.0B | $5.8B | ||
| Q2 24 | $1.9B | $5.7B | ||
| Q1 24 | $1.8B | $5.7B |
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.2M | $417.3M |
| Free Cash FlowOCF − Capex | $-12.4M | $379.8M |
| FCF MarginFCF / Revenue | -1.6% | 25.4% |
| Capex IntensityCapex / Revenue | 1.4% | 2.5% |
| Cash ConversionOCF / Net Profit | -0.50× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $14.4M | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.2M | $417.3M | ||
| Q3 25 | $47.3M | $402.6M | ||
| Q2 25 | $-5.7M | $263.6M | ||
| Q1 25 | $28.7M | $44.1M | ||
| Q4 24 | $-39.8M | $75.2M | ||
| Q3 24 | $79.6M | $188.4M | ||
| Q2 24 | $36.1M | $-95.6M | ||
| Q1 24 | $43.0M | $-308.6M |
| Q4 25 | $-12.4M | $379.8M | ||
| Q3 25 | $35.0M | $354.5M | ||
| Q2 25 | $-26.2M | $219.8M | ||
| Q1 25 | $18.0M | $-12.3M | ||
| Q4 24 | $-57.4M | $-17.3M | ||
| Q3 24 | $68.5M | $54.7M | ||
| Q2 24 | $26.3M | $-205.5M | ||
| Q1 24 | $32.4M | $-465.1M |
| Q4 25 | -1.6% | 25.4% | ||
| Q3 25 | 5.3% | 25.1% | ||
| Q2 25 | -4.3% | 16.7% | ||
| Q1 25 | 2.8% | -1.1% | ||
| Q4 24 | -7.7% | -1.5% | ||
| Q3 24 | 10.0% | 5.5% | ||
| Q2 24 | 4.0% | -22.1% | ||
| Q1 24 | 4.6% | -61.9% |
| Q4 25 | 1.4% | 2.5% | ||
| Q3 25 | 1.9% | 3.4% | ||
| Q2 25 | 3.3% | 3.3% | ||
| Q1 25 | 1.7% | 5.0% | ||
| Q4 24 | 2.4% | 8.2% | ||
| Q3 24 | 1.6% | 13.3% | ||
| Q2 24 | 1.5% | 11.8% | ||
| Q1 24 | 1.5% | 20.8% |
| Q4 25 | -0.50× | 6.28× | ||
| Q3 25 | 7.05× | 3.22× | ||
| Q2 25 | -0.81× | 2.79× | ||
| Q1 25 | 5.82× | 34.71× | ||
| Q4 24 | -0.96× | — | ||
| Q3 24 | 2.66× | — | ||
| Q2 24 | 1.17× | — | ||
| Q1 24 | 0.77× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CAL
| Brand Portfolio | $383.7M | 49% |
| Landed Wholesale | $148.1M | 19% |
| Wholesale E Commerce | $75.0M | 9% |
| Ecommerce | $68.8M | 9% |
| Stuart Weitzman Brand | $45.8M | 6% |
| Landed Wholesale Ecommerce Drop Ship | $30.6M | 4% |
| First Cost Wholesale | $14.9M | 2% |
| Clt Brand Solutions | $10.2M | 1% |
| License And Royalty | $2.1M | 0% |
ONC
Segment breakdown not available.
